Treated in only 3 VISITS!   214.379.2700
  • Comparing Prostate Cancer Treatments

    Find the Most Effective Treatment - An international team of experts took on the task of Comparing Prostate Cancer Treatments for more than 100,000 patients over 15 years. The goal of the study was to determine who remained prostate cancer free after treatment. Making these treatment comparison results available to you, will help you find the most effective prostate... read more

  • Comparing Treatment Results of Prostate Cancer 2013

    Patients, physicians and carriers need a simple, unbiased means to compare the cancer control rates of modern prostate cancer treatment methods. To solve this problem, we have assembled experts from key treating disciplines: Surgery, External Radiation, Internal (or Brachytherapy), High Frequency Ultrasound, and Proton Therapy The purpose of this work is to do a complete review study of the... read more

  • Comparing Treatment Results of Prostate Cancer 2014

    Problem: Patients, physicians and carriers need a simple, unbiased means to compare the cancer control rates of modern prostate cancer treatment methods. To solve this problem, we have assembled experts from key treating disciplines: Surgery, External Radiation, Internal (or Brachytherapy), High Frequency Ultrasound, and Proton Therapy to do a complete review study of the current literature on prostate cancer... read more

  • Biomarker can predict aggressive prostate cancer

    When a man is diagnosed with prostate cancer, a host of tools can be used to determine the type and extent of his disease. These tools include a basic PSA blood test, digital rectal exam, tissue biopsy, and a Gleason Score – a mathematical score based on tissue analysis that predicts whether the cancer is aggressive or not and... read more

  • Prostate Brachytherapy Has Good Long-term Outcomes

    Stone and Stock reported a large cohort study, published in the Journal of Urology, of more than 1700 men treated for prostate cancer between 1990 and 2007, with a 10-year mean follow-up. The study included a mixture of patients and treatments: Some men received brachytherapy with iodine alone, and some received brachytherapy with palladium, with or without hormone therapy,... read more

  • Study Supports IL16 Role in Prostate Cancer in African-Americans

    In African-Americans, IL16 polymorphisms appear to play a role in prostate cancer susceptibility, according to research published online Aug 24 in Cancer Epidemiology, Biomarkers & Prevention. Interleukin 16 (IL-16), small cell-signaling protein molecules that are released by a variety of cells (including lymphocytes and some epithelial cells) that has been characterized as a chemoattractant for certain immune cells expressing the... read more

  • Improved Survival for Prostate Cancer Seen in Post-PSA Era

    Overall survival for metastatic prostate cancer is significantly improved in a post-prostate-specific antigen (PSA) era trial compared with two trials conducted before the PSA era. Prostate-specific antigen, or PSA, is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to... read more

Page 1 of 3123